Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 142 (1996), 1231-1237; DOI  10.1099/13500872-142-5-1231
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brazeau, C.
Right arrow Articles by Martineau-Doizé, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brazeau, C.
Right arrow Articles by Martineau-Doizé, B.
Agricola
Right arrow Articles by Brazeau, C.
Right arrow Articles by Martineau-Doizé, B.

In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages

C. Brazeau1, M. Gottschalk1, S. Vincelette1 and B. Martineau-Doizé1,2

Groupe de Recherche sur les Maladies Infectieuses du Porc, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada J2S 7C6

2Author for correspondence: B. Martineau-Doizé. Tel: +1 514 773 8521 ext. 8359. Fax: +1 514 778 8108. e-mail: doizeb@ere.umontreal.ca

ABSTRACT

In this study, data on phagocytosis of Streptococcus suis and its survival inside macrophages are presented. Mouse peritoneal macrophages were incubated in the presence of one of five different strains of S. suis capsular type 2: a virulent wild-type strain (1591), a non-capsulated non-virulent mutant strain (M2), a poorly capsulated non-virulent mutant strain (M42), a non-virulent capsulated strain (1330), and the wild-type reference (virulent) strain 5735. Opsonized or non-opsonized bacteria were incubated with macrophages in vitro and samples were obtained after 1 and 3 h incubation. Phagocytosis as well as live and dead intracellular organisms were determined by acridine orange and crystal violet staining. After 1 h incubation, non-opsonized virulent and non-virulent capsulated bacteria were poorly phagocytosed (by less than 7% of the macrophages), whereas the non-capsulated non-virulent mutant strain was highly phagocytosed (by more than 68% of the macrophages). The M42 mutant strain was more phagocytosed than the capsulated strains but less than the non-capsulated M2 mutant strain (35%). In contrast, a higher percentage of live bacteria was observed inside macrophages for the capsulated strains (1591 and S735) than for the non- or poorly capsulated mutant strains (M2 and M42). Opsonization of bacteria with rabbit serum or heat-inactivated rabbit serum significantly increased phagocytosis. For every opsonized strain, after 3 h incubation, the percentage of live bacteria within macrophages was considerably lower than the corresponding non-opsonized strains. In conclusion, the capsule of S. suis type 2 appears to act as an important anti-phagocytic factor. However, virulent capsulated non-opsonized strains can be phagocytosed by mouse peritoneal macrophages within which they appear to survive for at least 3 h. Serum factors other than complement increase not only phagocytosis but also intracellular killing of S. suis of both capsulated and non-capsulated strains.


Keywords: Streptococcus suis, capsule, opsonization, phagocytosis, intracellular survival




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
X. Pan, J. Ge, M. Li, B. Wu, C. Wang, J. Wang, Y. Feng, Z. Yin, F. Zheng, G. Cheng, et al.
The Orphan Response Regulator CovR: a Globally Negative Modulator of Virulence in Streptococcus suis Serotype 2
J. Bacteriol., April 15, 2009; 191(8): 2601 - 2612.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y. Li, M. Gottschalk, M. Esgleas, S. Lacouture, J. D. Dubreuil, P. Willson, and J. Harel
Immunization with Recombinant Sao Protein Confers Protection against Streptococcus suis Infection
Clin. Vaccine Immunol., August 1, 2007; 14(8): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Segura and M. Gottschalk
Streptococcus suis Interactions with the Murine Macrophage Cell Line J774: Adhesion and Cytotoxicity
Infect. Immun., August 1, 2002; 70(8): 4312 - 4322.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. D. Fuller, D. J. Bast, V. Nizet, D. E. Low, and J. C. S. de Azavedo
Streptococcus iniae Virulence Is Associated with a Distinct Genetic Profile
Infect. Immun., April 1, 2001; 69(4): 1994 - 2000.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. B. Gordon, G. R. B. Irving, R. A. Lawson, M. E. Lee, and R. C. Read
Intracellular Trafficking and Killing of Streptococcus pneumoniae by Human Alveolar Macrophages Are Influenced by Opsonins
Infect. Immun., April 1, 2000; 68(4): 2286 - 2293.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 Society for General Microbiology.